USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke DIRECT TO GOVERNMENT MARKETING wurde als Wortmarke am 04.05.2005 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".
Markeninhaber
215 East 68th Street, Suite 2N
10021 New York
US
10021 New York
US
Markenvertreter
Waren und Dienstleistungen
9
Electronic media, namely videos, DVDs, CDs and other prerecorded media in the field of healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
16
Publications, namely books, magazines, brochures, newsletters in the field of healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
35
Consulting services in the field of healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, prescription practices, formulary design, pricing and reimbursement ; promoting public awareness of the need for improving healthcare through the development of public and private-sector policy initiatives for improving the nature, quality, access to and delivery of healthcare; providing information and informational resources regarding the healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, marketing, advertising, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
41
Educational services, namely conducting conferences, meetings and seminars in the fields of healthcare, the healthcare industry and healthcare policy and distribution of course materials in connection therewith; educational and advocacy services, including providing policy and strategy recommendations in the field of healthcare in collegiate and graduate institutions; providing online educational information and resources in the fields of the healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, marketing, advertising, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
42
Conducting research in the field of healthcare regarding the healthcare policy, economics, politics, access to and delivery of healthcare and pharmaceuticals, marketing, advertising, public relations, and issues which affect research, development, drug design, quality control, new drug approval, marketing, advertising, prescription practices, formulary design, pricing and reimbursement in pharmaceutical, biotechnology, medical device, medical insurance, hospital and pharmacy benefit industries
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1378623280